A simplified protocol for deep quantitative proteomic analysis of gingival crevicular fluid for skeletal maturity indicators
Analytica Chimica Acta · 2024
DOI: 10.1016/j.aca.2024.342342 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Analytica Chimica Acta, 2024. Verfasst von Xue Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200433, PR China. Hauptthemen laut MEDLINE: Proteome, Gingival Crevicular Fluid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Earth Institute, Columbia University, National Natural Science Foundation of China, School of Medicine, Shanghai Jiao Tong University.
Abstract (Originalsprache)
Assessment of craniofacial skeletal maturity is of great importance in orthodontic diagnosis and treatment planning. Traditional radiographic methods suffer from clinician subjectivity and low reproducibility. Recent biochemical methods, such as the use of gingival crevicular fluid (GCF) protein biomarkers involved in bone metabolism, have provided new opportunities to assess skeletal maturity. However, mass spectrometry (MS)-based GCF proteomic analysis still faces significant challenges, including the interference of high abundance proteins, laborious sample prefractionation and relatively limited coverage of GCF proteome. To improve GCF sample processing and further discover novel biomarkers, we herein developed a single-pot, solid-phase-enhanced sample-preparation (SP3)-based high-field asymmetric waveform ion mobility spectrometry (FAIMS)-MS protocol for deep quantitative analysis of the GCF proteome for skeletal maturity indicators. SP3 combined with FAIMS could minimize sample loss and eliminate tedious and time-consuming offline fractionation, thereby simplifying GCF sample preparation and improving analytical coverage and reproducibility of the GCF proteome. A total of 5407 proteins were identified in GCF samples from prepubertal and circumpubertal groups, representing the largest dataset of human GCF proteome to date. Compared to the prepubertal group, 61 proteins were differentially expressed (31 up-regulated, 30 down-regulated) in the circumpubertal group. The six-protein marker panel, including ATP5D, CLTA, CLTB, DNM2, HSPA8 and NCK1, showed great potential to predict the circumpubertal stage (ROC-AUC 0.937), which provided new insights into skeletal maturity assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200433, PR China.
- Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200125, PR China. Electronic address: rjliao@shsmu.edu.cn.
- Shanghai Institute of Precision Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200125, PR China. Electronic address: caiyan0723@shsmu.edu.cn.
Förderung
- Earth Institute, Columbia University
- National Natural Science Foundation of China
- School of Medicine, Shanghai Jiao Tong University
Zitieren
APA
Yang, X., Wang, J., Liao, R., & Cai, Y. (2024). A simplified protocol for deep quantitative proteomic analysis of gingival crevicular fluid for skeletal maturity indicators. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2024.342342
Vancouver
Yang X, Wang J, Liao R, Cai Y. A simplified protocol for deep quantitative proteomic analysis of gingival crevicular fluid for skeletal maturity indicators. Analytica Chimica Acta. 2024. doi:10.1016/j.aca.2024.342342
BibTeX
@article{Yang2024,
author = {Yang, Xue and Wang, Jun and Liao, Rijing and Cai, Yan},
title = {A simplified protocol for deep quantitative proteomic analysis of gingival crevicular fluid for skeletal maturity indicators},
journal = {Analytica Chimica Acta},
year = {2024},
doi = {10.1016/j.aca.2024.342342}
}
EUVIMED